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Several immunomodulatory factors are involved in malaria pathogenesis. Among them, heme has been shown to play a role in
the pathophysiology of severe malaria in rodents, but its role in human severe malaria remains unclear. Circulating levels of to-
tal heme and its main scavenger, hemopexin, along with cytokine/chemokine levels and biological parameters, including hemo-
globin and creatinine levels, as well as transaminase activities, were measured in the plasma of 237 Plasmodium falciparum-in-
fected patients living in the state of Odisha, India, where malaria is endemic. All patients were categorized into well-defined
groups of mild malaria, cerebral malaria (CM), or severe noncerebral malaria, which included acute renal failure (ARF) and hep-
atopathy. Our results show a significant increase in total plasma heme levels with malaria severity, especially for CM andmalar-
ial ARF. Spearman rank correlation and canonical correlation analyses have shown a correlation between total heme, he-
mopexin, interleukin-10, tumor necrosis factor alpha, gamma interferon-induced protein 10 (IP-10), andmonocyte chemotactic
protein 1 (MCP-1) levels. In addition, canonical correlations revealed that heme, along with IP-10, was associated with the CM
pathophysiology, whereas both IP-10 andMCP-1 together with heme discriminated ARF. Altogether, our data indicate that
heme, in association with cytokines and chemokines, is involved in the pathophysiology of both CM and ARF but through differ-
ent mechanisms.
In 2008, India alone accounted for 27% of malaria cases outsideAfrica (http://www.who.int/malaria/world_malaria_report_20
10/worldmalariareport2010.pdf?ua1). The central and eastern
regions of India are the most vulnerable to malaria, with the state
of Odisha alone accounting for 40% of all malaria cases and
88% of Plasmodium falciparum infections recorded in India in
2009 (http://nvbdcp.gov.in/malaria-new.html). Although cere-
bral complications are equally frequent among adults and chil-
dren, adults are more susceptible to developing multiple malaria-
related complications (1). Indeed, a shift in clinical profile has
been observed in the last 10 years, with more cases of multiple
complications, includingmalarial acute renal failure (ARF) (1, 2).
Mechanisms underlying this shift are not clearly understood and
need to be further investigated.
As a consequence of the massive destruction of red blood cells
(RBCs) during infection, immunogenic molecules are released
into the bloodstream, and they play a major role in determining
the clinical outcome (3). Although themalarial parasite uses 60 to
80% of hemoglobin for growth and converts most of the heme
into hemozoin, there is also significant release of hemoglobin into
the blood from nonparasitized RBCs (4). Cell-free hemoglobin is
readily oxidized, releasing its heme prosthetic groups (5). Under
aerobic conditions, heme is essential to life when bound to hemo-
proteins. However, free heme is involved in immune-mediated
diseases by inducing the production of reactive oxygen species
(ROS) and proinflammatory cytokines (6, 7). Normally, extracel-
lular free heme is neutralized rapidly by hemopexin, forming a
heme-hemopexin complex. This complex then is scavenged by
macrophages and hepatocytes and further catabolized by heme
oxygenase-1 (HO-1) (5). Although the liver is the main site for
heme degradation, high levels of cell-free heme can overwhelm its
detoxifying capacity during hemolytic pathologies (8, 9).
In mice, injection of heme at later stages of malarial infection
triggered cerebral malaria (CM) and also was involved in hepa-
topathy and dyserythropoiesis (5, 10, 11). Interestingly, during P.
vivax infections in Brazil, plasma heme levels were found to in-
crease with disease severity (12). In addition, plasma levels of cell-
free hemoglobin increased with severity during P. falciparum in-
fection and could reflect increased systemic levels of heme (13),
andmore than 50% of P. falciparum-infected children developing
CM inZambia showed the presence of urinary heme, compared to
3.5% for uncomplicated cases (14).However, little is known about
heme in the pathophysiology of P. falciparum malaria. In this
study, we investigated its role in malarial outcomes of P. falci-
parum-infected patients from the state of Odisha, India, where
malaria is endemic. We also examined the correlation of plasma
levels of heme and hemopexin with circulating cytokine profiles
and malaria pathology. Our analysis revealed that heme levels in-
creased during CM and malarial ARF, while correlative studies
Received 7 May 2015 Returned for modification 30 May 2015
Accepted 3 July 2015
Accepted manuscript posted online 13 July 2015
Citation Dalko E, Das B, Herbert F, Fesel C, Pathak S, Tripathy R, Cazenave P-A,
Ravindran B, Sharma S, Pied S. 2015. Multifaceted role of heme during severe
Plasmodium falciparum infections in India. Infect Immun 83:3793–3799.
doi:10.1128/IAI.00531-15.
Editor: J. H. Adams
Address correspondence to Sylviane Pied, sylviane.pied@pasteur-lille.fr.
Supplemental material for this article may be found at http://dx.doi.org/10.1128
/IAI.00531-15.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.
doi:10.1128/IAI.00531-15
October 2015 Volume 83 Number 10 iai.asm.org 3793Infection and Immunity
with cytokines suggest that mechanisms involved in the two pa-
thologies are different.
MATERIALS AND METHODS
Ethics.This studywas conducted according to the guidelines set out in the
Declaration of Helsinki. The study was approved by the Institutional Hu-
man Ethics Committee of SCB Medical College, Cuttack, India, and the
Institutional Review Board of all three collaborating institutes: (i) the
Institute of Life Sciences, Bhubaneswar, India, (ii) the Tata Institute of
Fundamental Research, Mumbai, India, and (iii) Institut Pasteur de Lille,
Lille, France. The National Health Office Ethics committee in India ap-
proved the study design. All blood samples were collected after obtaining
written consent from participants or, in the case of comatose patients,
accompanying relatives.
Study site and participants. The study was conducted in India at the
SCB Medical College, Cuttack, Odisha, between 2008 and 2011. Patients
(n  237; age, >15 years) with a history of fever and with evidence of
altered sensorium, jaundice, oliguria, respiratory distress, shock, and/or
bleeding diathesis were screened for P. falciparum infection by Giemsa-
stained blood smears and an immune chromatography test (SD Bio Stan-
dard Diagnostics India). Patients who were positive for ICT but negative
by blood smears were subjected to nested PCR, as described earlier (15).
Those with evidence of sepsis were excluded. After diagnosis, all patients
received appropriate treatment.
Clinical categorization was based onmodified guidelines of theWorld
Health Organization (WHO) (15, 16). Mildmalaria (MM)was defined as
fever with evidence of P. falciparum infection. Severe malaria (SM) was
defined as patients having at least one feature of SM reported by theWHO
(16) and were further categorized into four groups based on distinct clin-
ical features: CM, SNCM (severe non-CM), MOD (multiple organ dys-
function), and CM-MOD (CM with MOD). CM was defined as patients
with a Glasgow coma score (GCS) of10. SNCM patients had one of the
severe manifestations without cerebral involvement, such as severe ane-
mia (hemoglobin, 5 g/dl), ARF (creatinine, 3 mg/dl), jaundice (bili-
rubin, 3 mg/dl), acute respiratory distress (ARDS; PaO2/FiO2, 200
mm Hg), metabolic acidosis (plasma bicarbonate,15 mmol/liter), and
systolic shock (systolic blood pressure, 80 mm Hg). Hepatopathy was
diagnosed either as ALT (alanine transaminase) and AST (aspartate
transaminase) at 3 times the normal level or as ALT and AST at 2
times the normal level, with bilirubin of6 mg/dl and alkaline phospha-
tase of 100 IU/ml in order to distinguish patients displaying liver dys-
functions from patients having solely jaundice. MOD patients had at least
two damaged organs, including ARF, hepatopathy, ARDS, and systolic
shock. When more than a single organ failure was associated with CM,
patients were considered CM-MOD.
Endemic controls (EC) of identical ethnicity and coming from a sim-
ilar geographical background were enrolled from among patients’ rela-
tives (n 37). Sepsis was defined as patients showing a systemic inflam-
matory response syndrome that had a proven or suspected microbial
etiology. Sepsis (n 10) and encephalitis cases (n 9) were admitted to
SCB Medical College. None of the control subjects reported a history of
clinical malaria in the 5 years preceding our study.
Blood collection, diagnosis, and biological parameters. Peripheral
venous bloodwas collected on the day of recruitment prior to initiation of
any treatment. Biological parameters such as complete blood count, renal
(creatinine) and liver (alkaline phosphatase, bilirubin, ALT, and AST)
function tests, blood sugar, electrolytes, and lactate levels were measured
for all samples. Patients with bleeding diathesis were assessed for platelet
count, prothrombin time, activated partial thromboplastin time, and fi-
brin degradation products for evidence of disseminated intravascular co-
agulation. All other patients had their platelets estimated. If there was
evidence of thrombocytopenia (100,000/mm3), a coagulation profile
was established to determine subclinical disseminated intravascular coag-
ulation. Viral markers for hepatitis A, E, B, and C were tested in patients
with hepatopathy and jaundice, and arterial blood gas analysis was per-
formed during ARDS.
Quantification of HRP-2. Plasma histidine-rich protein-2 (HRP-2)
levelsweremeasuredusing enzyme-linked immunosorbent assay (ELISA)
as described previously (17). An anti-P. falciparumHRP-2 IgM (MPFM-
55A; Santa Cruz Biotechnology, France) was used as the capture antibody,
an anti-P. falciparum HRP-2 IgG1 was used as a detection antibody
(MPFG-55; Santa Cruz Biotechnology, France), and a horseradish perox-
idase-coupled monoclonal anti-IgG1 antibody (SB77e; Abcam, France)
was used as the secondary antibody for detection. A standard curve was
added in duplicate to each plate, and it was obtained through serial dilu-
tions of a serum sample from a previously described cohort with known
parasitemia (18). Samples out of range of detection were more or less
diluted. The lower limit of detection was 0.5 arbitrary units (AU).
Determination of plasma levels of total heme and hemopexin.Total
heme levels weremeasured in plasma using the QuantiChrom heme assay
kit (BioAssay Systems, USA). Hemopexin levels were measured through
ELISA using the human hemopexin ELISA kit (Abcam, France).
Cytokinemeasurements. The concentrations of plasma cytokines for
each sample were measured in duplicate using the Milliplex MAP multi-
plex assay kit (Millipore, France). The Bio-Plex 200 system (Bio-Rad,
France) was used for detection, and data were analyzed with the Bio-Plex
Manager 5.0 software (Bio-Rad, France).
Statistical analysis. Statistical significance was determined by the
nonparametric Mann-Whitney test for pairwise comparisons, or the
Kruskal-Wallis test for multiple comparisons, using GraphPad Prism
software (version 5; GraphPad Prism Software, USA). Spearman rank cor-
relation analyses and canonical correlations were performed using Igor-
Pro software (WaveMetrics, USA). P 0.05 was considered significant.
RESULTS
Characteristics of patient groups. Among P. falciparum-infected
patients recruited in the study, 180 (76%) individuals had SM
(Table 1). Jaundice, severe anemia, and metabolic acidosis were
not considered to be organ dysfunctions but were included in the
SNCM group, and they accounted for 21% of SM cases (see Fig.
S1A in the supplementalmaterial). Nearly half of the patients with
SM (48%) had a single organ dysfunction (see Fig. S1B), with CM
being the most common complication (51%), followed by ARF
(40%), hepatopathy (7%), and systolic shock (2%) (see Fig. S1B);
23% and 8% had two and three damaged organs, respectively,
whereas only one patient had four dysfunctional organs (see Fig.
S1A). Among patients having two damaged organs, 83%hadARF,
66% had CM, and 46% had hepatopathy (see Fig. S1C). Only two
patients had ARDS that was associated with at least two other
damaged organs. It is noteworthy that age was not a predictor of
the severity ofmalaria (Table 1). A higher percentage ofmales was
observed among all malaria groups, which is in agreement with a
previous report (19). HRP-2 level has been shown to be a good
indicator of total parasite biomass (20). In this study, plasma levels
of HRP-2 were higher in SM patients than in MM patients, while
only CM and CM-MOD patients had significantly higher HRP-2
levels (Table 1).
Hemeandhemopexin levels in severemalaria.Tounderstand
the impact of heme in the pathophysiology of severe P. falciparum
malaria, we measured plasma levels of heme, which include both
free and protein-bound forms, in P. falciparum-infected patients
and correlated them with disease severity. Patients with systemic
(sepsis; n  10) and brain (encephalitis; n  9) inflammatory
disease also were included to assess whether any observed associ-
ation was malaria specific. We found no change in heme levels in
cases of encephalitis and sepsis. However, heme levels increased
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with malarial disease severity as well as with the number of dam-
aged organs (Fig. 1A and B). Mortality was observed only during
CM (n 6) and CM-MOD (n 9), and CM/CM-MOD patients
who did not survive had a 2-fold increase in heme levels compared
to those who survived (P  0.01; Mann-Whitney test). Also, we
noted an inverse correlation between heme and hemopexin levels
(R  0.416; P  0.0001). There was a 6-fold decrease in the
plasma levels of hemopexin in SM patients compared to that of
MMpatients or ECs, and hemopexin levels decreased significantly
with the number of damaged organs (Fig. 1C and D).
Heme/hemopexin levels and organ injuries. Systolic shock
cases were excluded from analysis because of the small number of
patients (n  4). Similar total heme levels were obtained in pa-
tients with a single organ dysfunction and those withMM (Fig. 1B
and 2A). However, hemopexin levels decreased significantly in
patients having one damaged organ (Fig. 1C), especially when the
brain and kidneywere involved but not the liver (Fig. 2B).We also
compared total heme and hemopexin levels according to the GCS.
Considering aGCSof6 to be indicative of a poor prognosis (21),
we grouped patients into three GCS categories: 6, 7 to 10,
and 10. Levels of total heme significantly increased when the
GCS was 6 (Fig. 2C) and were inversely correlated to plasma
hemopexin levels (Fig. 2D). Additionally, hemopexin levels were
lower in patients with malarial ARF but not with hepatopathy
(Fig. 2B). According to a Spearman’s rank correlation analysis,
creatinine levels correlated negatively with hemopexin and posi-
tively with total heme, whereas ALT correlated with total heme
levels only (Fig. 2E to H).
Correlation of heme and hemopexin levels with cytokines in
severe malaria. In order to assess whether plasma levels of total
heme and hemopexin were related to cytokine profiles in malaria,
we measured the plasma concentrations of the following cyto-
kines: granulocyte macrophage colony-stimulating factor, granu-
locyte colony-stimulating factor, alpha 2 interferon (IFN-2),
IFN-, interleukin-1 (IL-1), IL-1, IL-2, IL-3, IL-4, IL-5, IL-6,
IL-7, IL-8, IL-10, IL-12p40, IL-12p70, IL-13, IL-15, IL-17, IFN--
induced protein 10 (IP-10), macrophage inflammatory protein
1 (MIP-1), MIP-, monocyte chemotactic protein 1 (MCP-1),
tumor necrosis factor alpha (TNF-), and TNF-. IL-10, IP-10,
TNF-, and MCP-1 correlated with both heme and hemopexin
levels (see Table S1 in the supplemental material).
To understand the networks involved among these different
factors, we performed a canonical correlation analysis between
cytokine levels and biological parameters by including all study
TABLE 1 Baseline characteristics
Characteristic
No. of
patients % male Agee (yr)
Hemoglobine
(g/dl) HRP-2e (AU)
Creatininee
(mg/dl) ALTe (IU/liter) GCSe
MM 57 78.9 29 (22–39) 10.8 (9.6–12.6) 9.8 (1.1–20.6) 1.3 (1.0–1.5) 39.0 (28.7–51.0) 15
Severe malaria 180 82.2 29 (22–45) 10.0 (8.0–11.4) 22.8 (8.0–40.8)*** 2.2 (1.2–5.4) 58.0 (39.0–85.0) 11
CMa 48 81.3 28 (20–40) 10.2 (8.7–11.9) 22.5 (4.3–40.7)# 1.3 (1.1–1.7) 46.0 (33.3–60.8) 9
ARFb 23 91.3 30 (25–45) 9.6 (8.0–10.2) 28.1 (10.9–42.6) 7.0 (5.8–9.1) 41.0 (33.3–55.5) 15
Hepatopathyc 12 75.0 29 (26–40) 10.3 (9.2–11.0) 13.3 (1.6–25.0) 1.0 (0.8–1.2) 131.5 (99.8–189.0) 15
Systolic shockd 4 50.0 40 (40–46) 12.7 (7.4–13.6) 23.7 (20.2–37.4) 2.3 (1.3–2.7) 60.5 (44.3–70.8) 15
Other SNCMf 37 73.0 28 (22–40) 9.5 (6.4–12.0) 14.5 (5.1–29.3) 1.2 (0.9–1.6) 53.0 (33.0–72.0) 15
MOD 14 85.7 27 (22–53) 10.2 (8.7–11.6) 20.7 (3.0–34.6) 4.3 (3.0–8.6) 136.0 (93.3–160.0) 15
CM-MOD 42 90.5 35 (23–47) 9.6 (8.0–11.4) 34.1 (20.9–54.2)### 5.4 (3.8–8.1) 68.0 (50.5–104.5) 9
Total 237 76.6 29 (22–41) 10.0 (8.3–12.0) 20.5 (5.6–34.5) 1.6 (1.1–4.2) 52.0 (36.0–79.5) 15
a CM was diagnosed as a GCS of10.
b ARF was diagnosed as plasma creatinine levels of3 mg/dl.
c Hepatopathy was diagnosed as ALT and AST at3 times the normal level or as AST at2 times the normal level and bilirubin levels of6 mg/dl.
d Systolic shock was diagnosed as systolic blood pressure of80 mmHg.
e Values are medians (interquartile ranges). ***, P 0.001 for comparison of mild malaria (MM) and severe malaria cases using the Mann-Whitney test. P 0.05 (#) and P
0.001 (###) for comparisons of mild malaria cases, patients affected with cerebral malaria (CM), acute renal failure (ARF), hepatopathy, systolic shock, other sever noncerebral
malaria cases (SNCM), multiple organ dysfunction (MOD), and CM with MOD (CM-MOD) using the Kruskal-Wallis test with a Dunn’s posttest.
f Jaundice, severe anemia, acidosis, and disseminated intravascular coagulation.
FIG 1 Total heme levels and malaria severity. Total heme and hemopexin
levels weremeasured in the plasma of P. falciparum-infected patients and were
compared according to the different clinical outcomes, i.e., endemic controls
(EC), encephalitis (E), severe sepsis (S), mild malaria (MM), severe malarial
(SM) patients (A and C), and the number of damaged organs during malaria
(B and D). The dark lines indicate the medians. Data were analyzed using the
Kruskal-Wallis test with a Dunn’s posttest or, for panel B, with a linear trend
analysis. Symbols: 	, differences with the MM or with the group of patients
having 0 damaged organ; #, differences with the group of patients having 1
damaged organ; *, differences between selected groups. **, P 0.01; ***, P
0.001.
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patients. Canonical analysis is a multivariate analysis that distin-
guishes components of relationships between two sets of variables.
It can further describe, by coefficients, how variables combined in
one set explain a corresponding variable combination in a second
set and in each component, also called the canonical variate. The
negative or positive coefficient assigned for each variable predicts
the way of its contribution in the component. The two sets of
variables used in our analysis were the following: set X included
IL-10, IP-10, MCP-1, and TNF-, and set Y included creatinine,
heme, and hemopexin (Table 2). Analysis revealed two separate
significant canonical variates (first, P  0.0001; second, P 
0.0021). Total heme and creatinine contributed negatively to the
first canonical variate, while all cytokineswere positively related to
it. Within each set of variables, IP-10 and hemopexin had the
highest coefficients, suggesting that they were major contributors
to this component of the relationship (Table 2). IL-10 and IP-10
were positively associated with the second significant canonical
variate. The same also was true for heme, hemopexin, and creati-
nine, suggesting a positive correlation between these variables.
Interestingly, within this second canonical variate, MCP-1 and
creatinine had the highest coefficients (Table 2). The canonical
analysis indicates the existence of complex networks, while overall
only the plasma levels of MCP-1 were significantly higher during
malarial ARF than MM (Fig. 3A to D).
It is noteworthy that the plasma cytokine profile in CM pa-
tients was different from that observed in malarial ARF. Plasma
IL-10, IP-10,MCP-1, and TNF- levels were comparable between
CM and MM patients (Fig. 4A to D). Therefore, canonical corre-
lations between IL-10, IP-10, MCP-1, and TNF- (set X) and
heme, hemopexin, and the CM-specific GCS (set Y) also were
calculated (Table 3). Only one significant canonical variate was
found (P  0.0001), within which heme levels were negatively
associated with the component, while GCS and hemopexin were
positively associated with it. In addition, all of the cytokines from
the first set of variables were positively associated with the com-
ponent. This suggests that low plasma levels of heme are associ-
atedwith an increase inGCS and increased cytokine levels. In each
set of variables, IP-10 and hemopexin had the highest coefficients,
suggesting their major effect in the CM-related network.
DISCUSSION
Hemolytic conditions are responsible for the release of heme into
circulation. Despite its critical role in many biological processes,
free heme can be involved in the induction of pathogenic re-
FIG 2 Correlation between clinical features and biological parameters with total heme and hemopexin levels. (A and B) Total heme and hemopexin levels in the
plasma of P. falciparum patients were compared between mild malaria (MM) cases and individuals having only a single complication: cerebral malaria (brain),
hepatopathy (liver), andmalarial acute renal failure (kidney). (C andD) Total heme levels and hemopexin levels were compared according to the Glasgow coma
score (GCS) and also were correlated using a Spearman’s rank correlation test to alanine transaminase levels (ALT) (E and F) and creatinine levels (G and H) of
P. falciparum-infected patients. The dark lines indicate the medians. Data shown in panels A to D were analyzed using the Kruskal-Wallis test with a Dunn’s
posttest. In panel B, 	 indicates differences withMM, and in panels A to D, an asterisk indicates differences between selected groups. *, P 0.05; ***, P 0.001.
TABLE 2 Canonical correlation analysis of cytokine, total heme,
hemopexin, and creatinine levelsa
Variable and set
Canonical variate
1 2
X
IL-10 0.0308 0.0814
TNF- 0.0071 0.0103
IP-10 0.0751 0.0576
MCP-1 0.0605 0.1582
Y
Heme 0.0524 0.0419
Hemopexin 0.1207 0.1016
Creatinine 0.0376 0.2166
a Canonical correlation analysis was done using the data for all of the patients and was
calculated between the two sets of variables. Analysis revealed two separate significant
canonical variates (first, P 0.0001; second, P 0.0021). Each column describes one
of the two total canonical variates, with the respective coefficients for the variables in
each set. IL-10, IP-10, heme, hemopexin, and creatinine were positively correlated with
the second canonical variate, whereas MCP-1 and TNF- were negatively correlated
with it.
Dalko et al.
3796 iai.asm.org October 2015 Volume 83 Number 10Infection and Immunity
sponses (7). Therefore, to assess the role of heme in human ma-
laria, wemeasured the plasma levels of total heme and hemopexin
in P. falciparum-infected patients. We found that the highest total
heme levels were correlated inversely with hemopexin levels in
both CM and ARF patients. Thus, our results provide evidence
that the severity of P. falciparum malaria is associated with an
increase in total heme levels in plasma. Accordingly, heme levels
were particularly high in fatal cases with an increasing number of
affected organs but not in cases of hepatopathy. To our knowl-
edge, this study is the first to emphasize the deleterious effects of
heme in P. falciparum infection.
Hemopexin is themost important element of the heme-detox-
ifying system because of its high binding affinity to heme that
allows it to ferry heme from the bloodstream to scavenger cells (9).
The degradation of the heme-hemopexin complex is likely to re-
sult in a decrease in hemopexin levels during hemolysis, thereby
contributing to the systemic accumulation of heme (22).We have
shown previously that intraperitoneal injections of heme in mice
resulted in a decrease in hemopexin levels (10). Therefore, we
propose that hemopexin levels reflect free heme levels. Interest-
ingly, there is a negative correlation between total heme and he-
mopexin levels in malaria, suggesting that during infection,
mainly unbound heme is found in plasma. Hemopexin is a posi-
tive acute-phase protein, and previous studies have reported an
increase in the circulating levels of hemopexin and its precursor
during sepsis or in MM (23, 24). However, decreased levels of
hemopexin during severe sepsis also were associated with a low
survival prognosis, highlighting the importance of hemopexin in
the scavenging of free heme (23, 25). Our observation that heme
and hemopexin levels remained unchanged in the severe sepsis
and encephalitis groups strongly supports the association of sys-
temic accumulation of heme in malarial infection with the lysis of
infected RBCs but not with inflammatory conditions. This as-
sumption is reinforced by the significant correlation of heme with
HRP-2 (R  0.475; P  0.001), as HRP-2 levels are a good indi-
cator of the total body parasite biomass (20). Even though we did
not observed any correlation between total heme and hemoglobin
levels (R 0.015; P 0.839), we cannot exclude the contribution
of healthy RBCs to the systemic release of heme.
Our findings reveal that heme plays a role in the pathophysiol-
ogy of human CM, which also has been confirmed previously by
studies in mice (5). In India, CM is often associated with MOD,
includingmalarial ARF (26). In this study, 31%of SMpatients had
more than two damaged organs, and ARF was the second most
common cause of SM (see Fig. S1 in the supplemental material).
Despite the increasing incidence of malarial ARF in India, little is
known about its pathophysiology (2). ARF is a frequent compli-
cation in disorders associated with high levels of heme (8, 25, 27).
To our knowledge, we are the first to report increased heme levels
FIG 3 Cytokine levels duringMM and ARF. IL-10 (A), TNF- (B), IP-10 (C),
and MCP-1 (D) levels were measured in the plasma of P. falciparum-infected
patients havingmildmalaria (MM) or only malarial acute renal failure (ARF).
The dark lines indicate the medians. Data were analyzed using the Mann-
Whitney test. *, P 0.05; n.s., nonsignificant difference.
FIG 4 Cytokine levels during MM and CM. IL-10 (A), TNF- (B), IP-10 (C),
andMCP-1 (D) levels weremeasured in the plasma ofmildmalaria (MM) and
cerebralmalaria (CM) patients. The dark lines indicate themedians. Datawere
analyzed using the Mann-Whitney test. **, P  0.01; ***, P  0.001; n.s.,
nonsignificant difference.
TABLE 3 Canonical correlation analysis of cytokine, total heme, and
hemopexin levels and GCSa
Variable and set Canonical variate 1
X
IL-10 0.0420
TNF- 0.0009
IP-10 0.0753
MCP-1 0.0457
Y
Heme 0.0616
Hemopexin 0.1225
GCS 0.0578
a Canonical correlation analysis was done using the data for all patients and was
calculated between the two sets of variables. Analysis revealed one significant canonical
variate (P 0.0001). Heme was negatively associated with the component, whereas all
of the other variables from both sets were positively associated with it.
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duringmalarial ARF, pointing to a possible toxic effect of heme on
the kidneys during P. falciparum infections. During CM and ma-
larial ARF, it is likely that the heme-mediated pathophysiology
involves mechanical as well as immunological processes (8, 28,
29). Moreover, as a catalyzer of ROS generation, heme decreases
the intracellular levels of reduced glutathione, which is associated
with the modulation of the immune response through the polar-
ization of T lymphocytes andmacrophages toward T-helper 2 and
M2 profiles (10, 30).
Cumulative evidence in our study strongly indicates an immu-
nological network involving heme and cytokines, such as IL-10,
IP-10, MCP-1, and TNF-, in the pathophysiology of CM and
malarial ARF. As suggested previously, IP-10 levels seemed to be
regulated by hemopexin (31), but cytokine levels were not associ-
ated with the outcome of CM (32, 33). In fact, we have shown that
IP-10 alonewas not a predictor ofCM in theOdishi population (F.
Herbert, N. Tchitchek, D. Bansal, J. Jacques, S. Pathak, C. Bécavin,
C. Fesel, E. Dalko, P.-A. Cazenave, C. Preda, B. Ravindran, S.
Sharma, B. Das, and S. Pied, submitted for publication). In this
context and as suggested by canonical correlation analyses, IP-10
might be a major component of the complex immune network
involving heme and hemopexin in the pathophysiology of CM.
Despite a positive correlation between heme and creatinine levels,
malarial ARF was associated with increased levels of MCP-1 only,
indicating different immune-mediated mechanisms in the patho-
physiology of these twomalaria-driven complications.Heme- and
hemoglobin-induced renal damage is further associated with the
production of high levels of ROS and with an overexpression of
HO-1, which inhibits MCP-1 expression through a negative loop
(27, 34). In our canonical analysis, this may correspond to the
second canonical variate, where low levels for MCP-1 and TNF-
were related to high levels of heme. In addition, increased levels of
IL-10 were associated with increased levels of creatinine, which is
in agreement with the protective effect of IL-10 during ARF in
murine models (35). In contrast with this observation, the first
canonical variate was related to overall high cytokine/chemokine
levels rather than to high hemopexin, low heme, and low creati-
nine levels, highlighting the complexity of the networks involved
in the pathophysiology of ARF.
Although the pathophysiology of CM andmalarial ARF could,
in part, be driven by genetic and environmental factors, our results
suggest that IL-10, IP-10, MCP-1, and TNF-, along with heme
and hemopexin, contribute to the development of these condi-
tions via different regulatory mechanisms. We also suggest that
plasma heme and hemopexin levels are good indicators for differ-
entiating severe outcomes of P. falciparummalaria. To gain better
insight into the complex mechanisms underlying these regula-
tions, we will investigate, in further studies, the polymorphism in
the promoter of the HO-1 gene, HMOX1, that influences its ex-
pression and circulating levels of heme (36, 37).
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